日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

DDEL-33. NEO100 facilitates delivery of blood-brain barrier impenetrable drugs

DDEL-33。NEO100 可促进血脑屏障无法穿透的药物的递送。

Hsieh, Vincent H; Wyatt, Philip J; Woo Shim, Dong; Lee, Wonwoo; Woo Lee, Jin; Soo Kim, Bom; Bastias, Gonzalo F; Pino, Felipe; Parada, Cristian; Jofre, Magdalena; Henriquez, Hugo; Chaparro, Felipe; Ricci, Gianni; Gruenberger, Eric H; Stewart, Matthew G; Nunes, Gustavo A; Dalmau-Pastor, Miki; Vega, Jordi; Cordier, Guillame; MacArthur, Robert Bruce; Rockwell, Kenneth; Johnson, Amber; Vaughan, Roger; Coller, Barry S; Patch, David A; Andrews, Nicholas A; Torrez, Timothy; Sutherland, Charles R; Harrelson, Whitt; Agarwal, Abhinav; Shah, Ashish; Richter, Martinus; Milstrey, Alexander; Zech, Stefan; Grueter, Angelika; Evers, Julia; Raschke, Michael J; Ochman, Sabine; Richter, V; Bermont, A; Cohen, D L; Broide, E; Shirin, H; Swenson, Stephen; Wang, Weijun; Schonthal, Axel; Chen, Thomas

Unusual association of cervical arachnoid cyst and idiopathic intracranial hypertension

颈椎蛛网膜囊肿与特发性颅内高压的罕见关联

Alokayli, Shirin H; Maghrabi, Sarah A; Almotairi, Fawaz S; Elwatidy, Sherif M

P503 Inflammatory bowel disease video-consulting: a satisfaction survey during the second wave of Covid-19 pandemics

P503 炎症性肠病视频咨询:第二波新冠疫情期间的满意度调查

Richter, V; Bermont, A; Cohen, D L; Broide, E; Shirin, H; Todeschini, A

Counseling interactions between patients living with persistent pain and pharmacists in Australia: are we on the same page?

澳大利亚慢性疼痛患者与药剂师之间的咨询互动:我们是否达成共识?

Lau, Esther Tl; Tan, Shirin H; Antwertinger, Yasmin J; Hall, Tony; Nissen, Lisa M

Safety, tolerability and efficacy of a novel self-use biodegradable device for management of obesity

一种新型可生物降解的自用肥胖症管理装置的安全性、耐受性和有效性研究

Shirin, H; Richter, V; Matalon, S; Abramowich, D; Maliar, A; Shachar, E; Moss, S F; Broide, E

Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial

口服不可吸收的缓释型6-巯基嘌呤可在肠道局部发挥作用,产生全身免疫效应,并能缓解克罗恩病,且副作用发生率低:双盲II期临床试验结果

Israeli, E; Goldin, E; Fishman, S; Konikoff, F; Lavy, A; Chowers, Y; Melzer, E; Lahat, A; Mahamid, M; Shirin, H; Nussinson, E; Segol, O; Ya'acov, A Ben; Shabbat, Y; Ilan, Y

Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27(kip1)

慢性幽门螺杆菌感染诱导一种与 p27(kip1) 表达降低相关的抗凋亡表型

Shirin, H; Sordillo, E M; Kolevska, T K; Hibshoosh, H; Kawabata, Y; Oh, S H; Kuebler, J F; Delohery, T; Weghorst, C M; Weinstein, I B; Moss, S F

Helicobacter pylori induced apoptosis

幽门螺杆菌诱导细胞凋亡

Shirin, H; Moss, S F

The use of synthetic analogues of Arg-Gly-Asp (RGD) and soluble receptor of tumor necrosis factor to prevent acute and chronic experimental liver injury

利用Arg-Gly-Asp (RGD) 的合成类似物和肿瘤坏死因子可溶性受体预防急性和慢性实验性肝损伤

Bruck, R; Hershkoviz, R; Lider, O; Shirin, H; Aeed, H; Halpern, Z